3518

    500420

    TORNTPHARM

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    TORRENT PHARMACEUTICALS L Share Price Today

    TORRENT PHARMACEUTICALS L is currently trading at ₹4768.3, up by ₹106.89 from the previous close. The stock touched an intraday high of ₹4783.00 and a low of ₹4680.00 during the latest trading session. Over the past one year, TORRENT PHARMACEUTICALS L has delivered a return of 43.01%, while the stock has gained 9.15% in the last one month.

    TORRENT PHARMACEUTICALS L performance

    Today’s low Today’s high
    ₹ 4680.00 ₹ 4783.00
    ₹ 4768.30
    52 week low 52 week high
    ₹ 3287.30 ₹ 4783.00
    ₹ 4768.30
    Open Price ₹ 4680.00
    Prev. Close ₹ 4661.40
    Volume (Shares) 345920.00
    Total traded value ₹ 16494.50
    Upper Circuit ₹ 5127.50
    Lower Circuit ₹ 4195.30
    info

    Investment Returns

    Over 1 Month 9.15% Over 3 Months 18.86% Over 6 Months 23.21% Over 1 Year 43.01%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    TORRENT PHARMACEUTICALS L fundamentals


    • Market cap (Cr) 1,61,380.90
    • P/E Ratio (TTM) 73.60
    • Beta 0.31
    • Book Value / share 249.73
    • Return on equity 27.32%
    • EPS (TTM) 65.37
    • Dividend yield 0.80%
    • Net profit/quarter (Cr) 467.00
    info icon alternate text
    • Market cap (Cr) 1,61,289.60
    • P/E Ratio (TTM) 73.60
    • Beta 0.26
    • Book Value / share 249.73
    • Return on equity 27.32%
    • EPS (TTM) 65.37
    • Dividend yield 0.80%
    • Net profit/quarter (Cr) 467.00
    info icon alternate text

    TORRENT PHARMACEUTICALS L Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 2677.00
    Operating Expense 2154.00
    Net Profit 467.00
    Net Profit Margin (%) 17.44
    Earnings Per Share (EPS) 13.80
    EBITDA 1014.00
    Effective Tax Rate (%) 21.11
    Particulars DEC 2025 (Values in Cr)
    Revenue 2547.00
    Operating Expense 1824.00
    Net Profit 577.00
    Net Profit Margin (%) 22.65
    Earnings Per Share (EPS) 17.04
    EBITDA 982.00
    Effective Tax Rate (%) 23.77
    Particulars SEP 2025 (Values in Cr)
    Revenue 2707.00
    Operating Expense 1916.00
    Net Profit 597.00
    Net Profit Margin (%) 22.05
    Earnings Per Share (EPS) 17.64
    EBITDA 1032.00
    Effective Tax Rate (%) 25.93
    Particulars JUN 2025 (Values in Cr)
    Revenue 2567.00
    Operating Expense 1869.00
    Net Profit 551.00
    Net Profit Margin (%) 21.46
    Earnings Per Share (EPS) 16.28
    EBITDA 974.00
    Effective Tax Rate (%) 25.74
    Particulars MAR 2025 (Values in Cr)
    Revenue 2385.00
    Operating Expense 1802.00
    Net Profit 474.00
    Net Profit Margin (%) 19.87
    Earnings Per Share (EPS) 14.00
    EBITDA 859.00
    Effective Tax Rate (%) 23.79
    Particulars MAR 2026 (Values in Cr)
    Revenue 10498.00
    Operating Expense 7763.00
    Net Profit 2192.00
    Net Profit Margin (%) 20.88
    Earnings Per Share (EPS) 64.75
    EBITDA 4002.00
    Effective Tax Rate (%) 24.33
    Particulars MAR 2025 (Values in Cr)
    Revenue 9485.00
    Operating Expense 7080.00
    Net Profit 1888.00
    Net Profit Margin (%) 19.90
    Earnings Per Share (EPS) 55.79
    EBITDA 3583.00
    Effective Tax Rate (%) 27.66
    Particulars MAR 2024 (Values in Cr)
    Revenue 8370.00
    Operating Expense 6707.00
    Net Profit 1357.00
    Net Profit Margin (%) 16.21
    Earnings Per Share (EPS) 40.10
    EBITDA 2981.00
    Effective Tax Rate (%) 29.21
    Particulars MAR 2023 (Values in Cr)
    Revenue 7547.00
    Operating Expense 6200.00
    Net Profit 1052.00
    Net Profit Margin (%) 13.93
    Earnings Per Share (EPS) 31.07
    EBITDA 2547.00
    Effective Tax Rate (%) 33.29
    Particulars MAR 2022 (Values in Cr)
    Revenue 6666.00
    Operating Expense 5480.00
    Net Profit 991.00
    Net Profit Margin (%) 14.86
    Earnings Per Share (EPS) 58.59
    EBITDA 2304.00
    Effective Tax Rate (%) 32.40
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 247.84
    ROE % 26.76
    ROCE % 18.30
    Total Debt to Total Equity 1.14
    EBITDA Margin 22.70
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 224.27
    ROE % 26.46
    ROCE % 25.84
    Total Debt to Total Equity 0.50
    EBITDA Margin 32.30
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 202.57
    ROE % 25.38
    ROCE % 23.21
    Total Debt to Total Equity 0.72
    EBITDA Margin 32.76
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 183.13
    ROE % 20.50
    ROCE % 19.48
    Total Debt to Total Equity 0.78
    EBITDA Margin 30.01
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 351.75
    ROE % 18.26
    ROCE % 18.20
    Total Debt to Total Equity 0.76
    EBITDA Margin 30.77
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 249.72
    ROE % 27.32
    ROCE % 19.18
    Total Debt to Total Equity 1.05
    EBITDA Margin 37.35
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 224.32
    ROE % 26.18
    ROCE % 26.84
    Total Debt to Total Equity 0.41
    EBITDA Margin 37.00
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 201.76
    ROE % 20.43
    ROCE % 20.40
    Total Debt to Total Equity 0.60
    EBITDA Margin 34.93
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 190.75
    ROE % 16.43
    ROCE % 17.68
    Total Debt to Total Equity 0.62
    EBITDA Margin 33.10
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 374.94
    ROE % 16.02
    ROCE % 16.57
    Total Debt to Total Equity 0.63
    EBITDA Margin 34.19
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 1165.20
    Total Assets 44311.96
    Total Liabilities 44311.96
    Total Equity 17584.83
    Share Outstanding 33
    Price to Book Ratio 16.90
    Return on Assets (%) 4.88
    Return on Capital (%) 6.68
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 579.46
    Total Assets 14989.74
    Total Liabilities 14989.74
    Total Equity 7590.69
    Share Outstanding 33
    Price to Book Ratio 14.42
    Return on Assets (%) 12.75
    Return on Capital (%) 18
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 839.04
    Total Assets 15060.58
    Total Liabilities 15060.58
    Total Equity 6856.15
    Share Outstanding 33
    Price to Book Ratio 12.89
    Return on Assets (%) 10.99
    Return on Capital (%) 15.35
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 571.46
    Total Assets 15011.85
    Total Liabilities 15011.85
    Total Equity 6198.07
    Share Outstanding 33
    Price to Book Ratio 8.06
    Return on Assets (%) 8.29
    Return on Capital (%) 10.83
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 403.41
    Total Assets 13099.84
    Total Liabilities 13099.84
    Total Equity 5952.95
    Share Outstanding 16
    Price to Book Ratio 7.46
    Return on Assets (%) 5.93
    Return on Capital (%) 7.79
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 82.98
    Total Assets 25813.53
    Total Liabilities 25813.53
    Total Equity 8452.17
    Share Outstanding 33
    Price to Book Ratio 16.90
    Return on Assets (%) 8.49
    Return on Capital (%) 9.69
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 109.74
    Total Assets 12841.76
    Total Liabilities 12841.76
    Total Equity 7592.50
    Share Outstanding 33
    Price to Book Ratio 14.42
    Return on Assets (%) 14.70
    Return on Capital (%) 18.62
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 108.76
    Total Assets 12376.59
    Total Liabilities 12376.59
    Total Equity 6828.76
    Share Outstanding 33
    Price to Book Ratio 12.89
    Return on Assets (%) 10.96
    Return on Capital (%) 13.35
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 147.61
    Total Assets 12871.93
    Total Liabilities 12871.93
    Total Equity 6455.96
    Share Outstanding 33
    Price to Book Ratio 8.06
    Return on Assets (%) 8.16
    Return on Capital (%) 9.54
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 69.46
    Total Assets 11152.56
    Total Liabilities 11152.56
    Total Equity 6345.42
    Share Outstanding 16
    Price to Book Ratio 7.46
    Return on Assets (%) 8.88
    Return on Capital (%) 10.23
    Particulars MAR 2026 (Values in Cr)
    Net Income 2872.19
    Cash from Operations 3831.63
    Cash from Investing -12712.41
    Cash from Financing 10150.60
    Net change in Cash 460.90
    Free Cash Flow 4509.02
    Particulars MAR 2025 (Values in Cr)
    Net Income 2672.81
    Cash from Operations 3187.93
    Cash from Investing -540.05
    Cash from Financing -2297.99
    Net change in Cash -252.93
    Free Cash Flow 3799.79
    Particulars MAR 2024 (Values in Cr)
    Net Income 2352.11
    Cash from Operations 3764.18
    Cash from Investing -167.90
    Cash from Financing -2779.64
    Net change in Cash 318.54
    Free Cash Flow 4196.96
    Particulars MAR 2023 (Values in Cr)
    Net Income 1847.16
    Cash from Operations 2766.20
    Cash from Investing -2415.31
    Cash from Financing 77.36
    Net change in Cash 30.18
    Free Cash Flow 3340.14
    Particulars MAR 2022 (Values in Cr)
    Net Income 1225.91
    Cash from Operations 2224.01
    Cash from Investing -196.63
    Cash from Financing -1781.05
    Net change in Cash -174.69
    Free Cash Flow 2426.58
    Particulars MAR 2026 (Values in Cr)
    Net Income 2896.61
    Cash from Operations 3446.77
    Cash from Investing -12990.20
    Cash from Financing 10225.23
    Net change in Cash -34.14
    Free Cash Flow 3956.32
    Particulars MAR 2025 (Values in Cr)
    Net Income 2610.18
    Cash from Operations 3064.61
    Cash from Investing -470.09
    Cash from Financing -2104.46
    Net change in Cash -0.05
    Free Cash Flow 3510.70
    Particulars MAR 2024 (Values in Cr)
    Net Income 1916.57
    Cash from Operations 3217.78
    Cash from Investing -296.07
    Cash from Financing -2577.57
    Net change in Cash 19.46
    Free Cash Flow 3562.12
    Particulars MAR 2023 (Values in Cr)
    Net Income 1577.02
    Cash from Operations 2537.87
    Cash from Investing -2384.07
    Cash from Financing 80.74
    Net change in Cash -37.92
    Free Cash Flow 3108.77
    Particulars MAR 2022 (Values in Cr)
    Net Income 1466.21
    Cash from Operations 2380.37
    Cash from Investing -159.70
    Cash from Financing -1977.27
    Net change in Cash 3.13
    Free Cash Flow 2488.54
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.72 13.52 1.58 250.74 23.12 38.85
    BLISS GVS PHARMA LTD 506.15 40.69 4.49 5368.04 118.35 552.90
    CIPLA LTD. 1458.45 30.95 3.42 117820.20 1165.55 1672.20
    FERMENTA BIOTECH LTD. 345.85 15.26 2.50 1017.87 256.40 399.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.72 22.88 4.21 250.74 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 536.85 24.06 4.19 1552.07 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8297.90 108.37 23.76 20744.75 7630.00 9850.00
    BLISS GVS PHARMA LTD 506.15 54.72 4.64 5368.04 118.35 552.90

    TORRENT PHARMACEUTICALS L shareholding pattern

    Holding
    6.44%
    68.3%
    16.17%
    9.06%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    TORRENT PHARMACEUTICALS L Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    4768.30 2.29 redarrow
    red-green-graph indicator
    0 Bearish
    16 Bullish
    • 5 Days 4666.80
    • 26 Days 4518.90
    • 10 Days 4608.40
    • 50 Days 4438.10
    • 12 Days 4592.10
    • 100 Days 4303.20
    • 20 Days 4545.10
    • 200 Days 4086.30
    4652.40 PIVOT
    First Support 4629.80 First Resistance 4684.00 Second Support 4598.20 Second Resistance 4706.60 Third Support 4575.60 Third Resistance 4738.20
    RSI 70.39 ADX 14.91 MACD 73.23 Williams % R -3.62 Commodity Channel Index (CCI) 194.13
    Date 2026-07-03 Week 385126.00 Same Day 153099.00 Month 280382.00
    1 Year 0.31 3 Year 0.41
    Over 1 Month
    9.15% down
    Over 1 Year
    43.01% down
    Over 3 Months
    18.86% down
    Over 3 Years
    36.11% down
    Over 6 Months
    23.21% down
    Over 5 Years
    26.54% down

    TORRENT PHARMACEUTICALS L Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    29 May 2026 9.0 Final 29 May 2026 Equity shares
    18 Feb 2026 29.0 Interim 19 Feb 2026 Equity shares
    20 Jun 2025 6.0 Final 20 Jun 2025 Equity shares
    31 Jan 2025 26.0 Interim 01 Feb 2025 Equity shares
    21 Jun 2024 6.0 Final 21 Jun 2024 Equity shares
    12 Feb 2024 22.0 Interim 12 Feb 2024 Equity shares
    23 Jun 2023 8.0 Final 23 Jun 2023 Equity shares
    03 Feb 2023 14.0 Interim 03 Feb 2023 Equity shares
    03 Jun 2022 8.0 Final 06 Jun 2022 Equity shares
    03 Jun 2022 15.0 Special 06 Jun 2022 Equity shares
    02 Feb 2022 25.0 Interim 03 Feb 2022 Equity shares
    17 Jun 2021 15.0 Final 18 Jun 2021 Equity shares
    15 Feb 2021 20.0 Interim 16 Feb 2021 Equity shares
    18 Mar 2020 15.0 Special 19 Mar 2020 Equity shares
    18 Mar 2020 17.0 Interim 19 Mar 2020 Equity shares
    13 Jun 2019 4.0 Final 14 Jun 2019 Equity shares
    06 Feb 2019 13.0 Interim 07 Feb 2019 Equity shares
    18 Jun 2018 5.0 Final 20 Jun 2018 Equity shares
    15 Feb 2018 9.0 Interim 19 Feb 2018 Equity shares
    19 Jun 2017 4.0 Final 21 Jun 2017 Equity shares
    10 Feb 2017 10.0 Interim 13 Feb 2017 Equity shares
    16 Mar 2016 15.0 Interim 2 17 Mar 2016 Equity shares
    11 Feb 2016 20.0 Interim 12 Feb 2016 Equity shares
    15 Jun 2015 6.25 Final 17 Jun 2015 Equity shares
    02 Feb 2015 5.0 Interim 03 Feb 2015 Equity shares
    16 Jun 2014 5.0 Final 18 Jun 2014 Equity shares
    24 Jan 2014 5.0 Interim 27 Jan 2014 Equity shares
    10 Jun 2013 10.0 Special 12 Jun 2013 Equity shares
    10 Jun 2013 7.0 Final 12 Jun 2013 Equity shares
    01 Feb 2013 6.0 Interim 04 Feb 2013 Equity shares
    11 Jun 2012 2.5 Final 13 Jun 2012 Equity shares
    27 Jan 2012 6.0 Interim 30 Jan 2012 Equity shares
    06 Jun 2011 6.0 Final 08 Jun 2011 Equity shares
    06 Jun 2011 2.0 Special 08 Jun 2011 Equity shares
    04 Jun 2010 6.0 Final 08 Jun 2010 Equity shares
    08 Jun 2009 4.0 Final 10 Jun 2009 Equity shares
    19 Jun 2008 3.5 Final 23 Jun 2008 Equity shares
    23 Mar 2007 3.0 Interim 26 Mar 2007 Equity shares
    15 Jun 2006 0.0 Final 01 Jan 0001 Equity shares
    09 Jun 2005 0.0 Final 13 Jun 2005 Equity shares
    Ex-Date Ex-Bonus Ratio
    11 Jul 2022 08 Jul 2022 1:1
    24 Jul 2013 23 Jul 2013 1:1
    27 Feb 2006 20 Feb 2006 1:1
    Ex-Date Old FV NEW FV Record Date
    20 Feb 2006 10.0 5.0 27 Feb 2006
    Dividend date Dividend amount Dividend type Record date Instrument type
    29 May 2026 9.0 Final 29 May 2026 Equity shares
    18 Feb 2026 29.0 Interim 19 Feb 2026 Equity shares
    20 Jun 2025 6.0 Final 20 Jun 2025 Equity shares
    31 Jan 2025 26.0 Interim 01 Feb 2025 Equity shares
    21 Jun 2024 6.0 Final 21 Jun 2024 Equity shares
    12 Feb 2024 22.0 Interim 12 Feb 2024 Equity shares
    23 Jun 2023 8.0 Final 23 Jun 2023 Equity shares
    03 Feb 2023 14.0 Interim 03 Feb 2023 Equity shares
    03 Jun 2022 8.0 Final 06 Jun 2022 Equity shares
    03 Jun 2022 15.0 Special 06 Jun 2022 Equity shares
    02 Feb 2022 25.0 Interim 03 Feb 2022 Equity shares
    17 Jun 2021 15.0 Final 18 Jun 2021 Equity shares
    15 Feb 2021 20.0 Interim 16 Feb 2021 Equity shares
    18 Mar 2020 15.0 Special 19 Mar 2020 Equity shares
    18 Mar 2020 17.0 Interim 19 Mar 2020 Equity shares
    13 Jun 2019 4.0 Final 14 Jun 2019 Equity shares
    06 Feb 2019 13.0 Interim 07 Feb 2019 Equity shares
    18 Jun 2018 5.0 Final 20 Jun 2018 Equity shares
    15 Feb 2018 9.0 Interim 19 Feb 2018 Equity shares
    19 Jun 2017 4.0 Final 21 Jun 2017 Equity shares
    10 Feb 2017 10.0 Interim 13 Feb 2017 Equity shares
    16 Mar 2016 15.0 Interim 2 17 Mar 2016 Equity shares
    11 Feb 2016 20.0 Interim 12 Feb 2016 Equity shares
    15 Jun 2015 6.25 Final 17 Jun 2015 Equity shares
    02 Feb 2015 5.0 Interim 03 Feb 2015 Equity shares
    16 Jun 2014 5.0 Final 18 Jun 2014 Equity shares
    24 Jan 2014 5.0 Interim 27 Jan 2014 Equity shares
    10 Jun 2013 10.0 Special 12 Jun 2013 Equity shares
    10 Jun 2013 7.0 Final 12 Jun 2013 Equity shares
    01 Feb 2013 6.0 Interim 04 Feb 2013 Equity shares
    11 Jun 2012 2.5 Final 13 Jun 2012 Equity shares
    27 Jan 2012 6.0 Interim 30 Jan 2012 Equity shares
    06 Jun 2011 6.0 Final 08 Jun 2011 Equity shares
    06 Jun 2011 2.0 Special 08 Jun 2011 Equity shares
    04 Jun 2010 6.0 Final 08 Jun 2010 Equity shares
    08 Jun 2009 4.0 Final 10 Jun 2009 Equity shares
    19 Jun 2008 3.5 Final 23 Jun 2008 Equity shares
    23 Mar 2007 3.0 Interim 26 Mar 2007 Equity shares
    15 Jun 2006 0.0 Final 01 Jan 0001 Equity shares
    09 Jun 2005 0.0 Final 13 Jun 2005 Equity shares
    Ex-Date Ex-Bonus Ratio
    11 Jul 2022 08 Jul 2022 1:1
    24 Jul 2013 23 Jul 2013 1:1
    27 Feb 2006 20 Feb 2006 1:1
    Ex-Date Old FV NEW FV Record Date
    20 Feb 2006 10.0 5.0 27 Feb 2006

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Torrent Pharmaceuticals Ltd?

    Answer Field

    Torrent Pharmaceuticals Ltd share price is for NSE ₹ 4,768.30 & for BSE ₹ 4,762.70 as on Jul 03 2026 03:30 PM.

    What is the Market Cap of Torrent Pharmaceuticals Ltd Share?

    Answer Field

    The market cap of Torrent Pharmaceuticals Ltd for NSE ₹ 0.01 & for BSE ₹ 0.01 as on Jul 03 2026 03:30 PM.

    What is the 52 Week High and Low of Torrent Pharmaceuticals Ltd?

    Answer Field

    The 52 Week High and Low of Torrent Pharmaceuticals Ltd for NSE is ₹ 4,783.00 and ₹ 3,287.30 and for BSE is ₹ 4,782.00 and ₹ 3,289.55.

    What is 1 year return for Torrent Pharmaceuticals Ltd?

    Answer Field

    The 1 year returns on the stock has been 43.01%.

    What is the P/E Ratio of Torrent Pharmaceuticals Ltd Share?

    Answer Field

    As on Jul 03 2026 03:30 PM the price-to-earnings (PE) ratio for Torrent Pharmaceuticals Ltd share is 73.60.

    What is the PB ratio of Torrent Pharmaceuticals Ltd Share?

    Answer Field

    As on Jul 03 2026 03:30 PM, the price-to-book (PB) ratio for Torrent Pharmaceuticals Ltd share is 249.73.

    How to Buy Torrent Pharmaceuticals Ltd Share?

    Answer Field

    You can trade in Torrent Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Torrent Pharmaceuticals Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Torrent Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Torrent Pharmaceuticals Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |